Skip to content

Hero image: A woman waking rested beside an open window with soft natural morning light

All insights

Transitions & Midlife

Sleep Disorders in Pregnancy and Menopause: More Than a Tiredness Story

9 min readEvidence synthesis
Read the evidence

The question in focus

An evidence-based review of insomnia, sleep apnoea, restless legs and sleep disruption during pregnancy, postpartum and menopause.

Evidence at a glance

50.8%

pooled prevalence of poor sleep quality during menopause

A 2024 meta-analysis reported a pooled estimate of 50.8%, with substantial differences among studies and populations.

Prevalence of Poor Sleep Quality During Menopause: A Meta-Analysis

Sleep changes are common, but common is not harmless

Pregnancy, postpartum and menopause can alter sleep through hormonal change, physical symptoms, caregiving, mood, pain and changing risk of sleep disorders. A review reported insomnia symptoms in about 38.2% of pregnant people, while estimates vary by trimester, definition and population [1]. A 2024 meta-analysis estimated poor sleep quality in 50.8% of menopausal participants [2]. Neither number should be used to diagnose an individual.

The clinical question is not simply how many hours someone sleeps. It is whether there is insomnia, sleep-disordered breathing, restless legs, circadian disruption, mood disorder, medication effect or another medical cause. Daytime sleepiness, impaired driving, witnessed breathing pauses, gasping, severe snoring, morning headache, uncomfortable leg urges or persistent inability to sleep despite opportunity deserve structured assessment [3].

  • Ask about night symptoms and daytime function.
  • Do not normalise severe sleepiness or breathing pauses as an inevitable part of pregnancy.
  • Review mood, pain, reflux, urinary symptoms, medicines, caffeine and alcohol.

Pregnancy changes the airway and the differential diagnosis

Weight and fluid changes in pregnancy can increase snoring and obstructive sleep apnoea risk. A 2023 consensus guideline supported by ACOG recommends targeted screening in higher-risk pregnant people rather than universal screening because validated pregnancy-specific approaches and outcome evidence remain limited [4]. Diagnosis may use home sleep apnoea testing or laboratory polysomnography according to clinical context and local expertise.

Restless legs symptoms can also emerge or worsen, sometimes alongside iron deficiency. Insomnia may reflect nausea, pain, fetal movement, reflux, anxiety or a primary insomnia disorder. Each cause points to a different response. Consumer wearables cannot rule sleep apnoea in or out, and their sleep-stage estimates should not replace clinical testing. Device data may still help describe schedules or prompt a conversation if interpreted cautiously.

  • Escalate dangerous sleepiness, suspected sleep apnoea or cardiopulmonary symptoms.
  • Check clinically indicated contributors rather than treating all pregnancy sleep problems alike.
  • Use validated diagnostic pathways for suspected sleep-disordered breathing.

Postpartum sleep needs a safety plan, not impossible advice

Newborn care fragments sleep, but severe insomnia can coexist with depression, anxiety, OCD, bipolar disorder or postpartum psychosis. A person who cannot sleep even when another trusted adult is caring for the baby needs prompt assessment. Markedly reduced need for sleep with agitation, racing thoughts, confusion, hallucinations or fixed beliefs is an emergency rather than a routine sleep complaint.

Care planning can protect a consolidated sleep opportunity when feasible, distribute night responsibilities, address pain and feeding challenges, and screen mental health. ACOG's sleep guidance likewise emphasises assessment and treatment rather than dismissing persistent sleep problems [3]. Advice must fit the family's resources and infant-safety guidance. It should not imply that a parent failed because uninterrupted sleep is unavailable. Clinicians should document what practical support exists and arrange follow-up when sleep loss is affecting safety, mood or caregiving.

  • Ask whether the person can sleep when given a safe opportunity.
  • Separate fatigue from a reduced need for sleep.
  • Create an urgent route for rapidly escalating mental or behavioural change.

Vasomotor symptoms can repeatedly wake a person, while insomnia, sleep apnoea, mood symptoms, pain and chronic conditions may contribute independently. ACOG notes that hot flushes, mood disorders and sleep apnoea can all affect sleep during the menopause transition [3]. Treating only one presumed cause can therefore leave substantial symptoms untreated.

For chronic insomnia in adults, the American Academy of Sleep Medicine strongly recommends multicomponent cognitive behavioural therapy for insomnia and suggests against sleep hygiene as the only treatment [5]. CBT-I combines behavioural and cognitive methods and should be adapted to comorbidity and patient circumstances. Menopause symptom treatment, positive airway pressure for confirmed sleep apnoea, and management of restless legs or mood conditions may be considered according to diagnosis and individual benefit-risk review.

  • Screen for sleep apnoea even when insomnia is the presenting complaint.
  • Offer CBT-I for chronic insomnia rather than sleep tips alone.
  • Use shared decision making for menopause therapies and medicines.

Technology can extend care if it knows its limits

Digital CBT-I can improve access, but the AASM notes that platforms differ and many exclude pregnancy or complex psychiatric conditions [6]. Services should identify who is eligible, how progress is monitored and what happens if symptoms worsen. A programme should not market a generic relaxation app as equivalent to clinician-supported CBT-I.

Remote monitoring can be useful for positive airway pressure adherence or sleep diaries. The governance standard should include informed consent, data minimisation, clinical response thresholds and a way to correct misleading data. Sleep scores can create anxiety and over-monitoring, sometimes called orthosomnia, so the outcome should be daytime wellbeing and function rather than a perfect device score.

  • Confirm whether a digital programme was evaluated in the relevant population.
  • Define which alerts a clinician reviews and within what time.
  • Allow patients to pause tracking when measurement worsens sleep anxiety.

What the evidence cannot yet answer

  • Prevalence estimates use different sleep instruments and populations and show substantial heterogeneity.
  • Pregnancy-specific evidence for screening and treating obstructive sleep apnoea remains lower certainty than general adult evidence.
  • Many digital insomnia products exclude pregnancy or complex mental illness and should not be generalised beyond studied groups.

Questions worth taking into care

  1. Are there witnessed pauses, gasping, dangerous sleepiness or an urge to move the legs?
  2. Can you sleep when given the opportunity, or is there a reduced need for sleep?
  3. Which symptoms are waking you: hot flushes, pain, reflux, mood, urination or breathing?
  4. Is CBT-I available in person, by telehealth or through an evaluated digital programme?
  5. What will happen if remote data or symptoms indicate deterioration?

Source record

Evidence used in this review

Sources were selected for clinical authority, methodological relevance and traceability. Links open the original guidance, public-health record or research publication.

  1. [1]
    Common Sleep Disorders in Pregnancy: A Review

    International Journal of Environmental Research and Public Health · 2023

  2. [2]
  3. [3]
    Sleep Health and Disorders

    American College of Obstetricians and Gynecologists · 2025

  4. [4]
  5. [5]
  6. [6]
Editorial standard

This evidence synthesis is for general information. It does not diagnose a condition or replace care from a qualified health professional. Treatment choices depend on individual history, examination, local guidance and informed preference. Emergency or rapidly worsening symptoms need urgent local medical assessment.